ACCC COVID-19 Resource Center & Discussion Group
for Insights on Providing Optimal Patient Care During the Pandemic.
Providing a VOICE for Nevada's MULTIDISCIPLINARY CANCER CARE TEAMS and the PATIENTS THEY SERVE since 1993
Meetings & Education
State & Federal Resources
Off-Label Use Literature
Patient Advocacy Organizations
National Professional Organizations
NOS Corporate Members
Become a Corporate Member
Industry News Archive
COVID-19 Featured Resources
FDA Approves Pembrolizumab for Metastatic SCLC
On June 17, 2019, the U.S. Food and Drug Administration (FDA) granted accelerated approval to pembrolizumab (Keytruda, Merck) for patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy and at least one other prior line of therapy.
Read FDA announcement